• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓系细胞环氧合酶-2 缺失可减轻急性炎症反应,但不影响载脂蛋白 E 基因敲除小鼠动脉粥样硬化的发生。

Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice.

机构信息

Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Calif 90095, USA.

出版信息

Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):260-8. doi: 10.1161/ATVBAHA.109.198762. Epub 2009 Nov 19.

DOI:10.1161/ATVBAHA.109.198762
PMID:19926832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2859183/
Abstract

OBJECTIVE

The role of myeloid cell cyclooxygenase-2 (COX-2) in the progression of atherosclerosis has not been clearly defined.

METHODS AND RESULTS

We investigated the role of COX-2 expressed in the myeloid lineage in the development of atherosclerosis using a myeloid-specific COX-2(-/-) (COX-2(-M/-M)) mouse on a hyperlipidemic apolipoprotein (apo) E(-/-) background (COX-2(-M/-M)/apoE(-/-)). Myeloid COX-2 depletion resulted in significant attenuation of acute inflammation corresponding with decreased PGE(2) levels in an air pouch model. COX-2 depletion in myeloid cells did not influence development of atherosclerosis in COX-2(-M/-M)/apoE(-/-) when compared to apoE(-/-) littermates fed either chow or western diets. The unanticipated lack of contribution of myeloid COX-2 to the development atherosclerosis is not attributable to altered maintenance, differentiation, or mobilization of myeloid and lymphoid populations. Moreover, myeloid COX-2 depletion resulted in unaltered serum prostanoid levels and cellular composition of atherosclerotic lesions of COX-2(-M/-M)/apoE(-/-) mice.

CONCLUSIONS

Our results suggest that COX-2 expression in myeloid cells, including macrophages, does not influence the development of atherosclerosis in mice.

摘要

目的

髓样细胞环氧化酶-2(COX-2)在动脉粥样硬化进展中的作用尚未明确。

方法和结果

我们使用载脂蛋白 E(apoE)基因敲除背景下的骨髓特异性 COX-2 敲除(COX-2(-M/-M))小鼠(COX-2(-M/-M)/apoE(-/-))研究了髓样细胞中 COX-2 的表达在动脉粥样硬化发生中的作用。在气囊模型中,髓样 COX-2 的耗竭导致急性炎症明显减弱,相应的 PGE(2)水平降低。与喂食标准饮食或普通饮食的 apoE(-/-)同窝仔鼠相比,髓样细胞 COX-2 耗竭并未影响 COX-2(-M/-M)/apoE(-/-)小鼠动脉粥样硬化的发展。出乎意料的是,髓样 COX-2 对动脉粥样硬化发展的贡献缺失不能归因于骨髓和淋巴样细胞群的维持、分化或动员的改变。此外,髓样 COX-2 耗竭并未改变 COX-2(-M/-M)/apoE(-/-)小鼠的血清前列腺素水平和动脉粥样硬化病变的细胞组成。

结论

我们的结果表明,髓样细胞(包括巨噬细胞)中的 COX-2 表达并不影响小鼠动脉粥样硬化的发生。

相似文献

1
Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice.髓系细胞环氧合酶-2 缺失可减轻急性炎症反应,但不影响载脂蛋白 E 基因敲除小鼠动脉粥样硬化的发生。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):260-8. doi: 10.1161/ATVBAHA.109.198762. Epub 2009 Nov 19.
2
Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.白细胞介素 17 在载脂蛋白 E 缺陷小鼠炎症、动脉粥样硬化和血管功能中的作用。
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1565-72. doi: 10.1161/ATVBAHA.111.227629. Epub 2011 Apr 7.
3
Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.血清和糖皮质激素诱导激酶1在血管炎症和动脉粥样硬化发生中的关键作用。
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):547-57. doi: 10.1161/ATVBAHA.114.304454. Epub 2015 Jan 22.
4
Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.骨膜蛋白缺失通过改变炎症和细胞外基质重塑来预防小鼠动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):60-8. doi: 10.1161/ATVBAHA.115.306397. Epub 2015 Nov 12.
5
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice.脂肪酸酰胺水解酶缺乏增强动脉粥样硬化小鼠斑块内中性粒细胞募集。
Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):215-23. doi: 10.1161/ATVBAHA.112.300275. Epub 2012 Dec 13.
6
Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.辛伐他汀对载脂蛋白E基因敲除小鼠中CD36和钙蛋白酶-1的下调作用、炎症与动脉粥样硬化
J Vasc Res. 2017;54(3):123-130. doi: 10.1159/000464288. Epub 2017 Apr 28.
7
Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis.Bmper 抑制血管内皮细胞炎性黏附分子的表达,从而起到抗动脉粥样硬化的作用。
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2214-22. doi: 10.1161/ATVBAHA.112.252015. Epub 2012 Jul 5.
8
Heparanase promotes the onset and progression of atherosclerosis in apolipoprotein E gene knockout mice.肝素酶促进载脂蛋白 E 基因敲除小鼠动脉粥样硬化的发生和发展。
Atherosclerosis. 2024 May;392:117519. doi: 10.1016/j.atherosclerosis.2024.117519. Epub 2024 Mar 19.
9
Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.转化生长因子-β通路 ROCK1 分支的激活促进了糖尿病 ApoE 基因敲除小鼠中 RAGE 依赖性动脉粥样硬化的加速发展。
Circ Res. 2010 Apr 2;106(6):1040-51. doi: 10.1161/CIRCRESAHA.109.201103. Epub 2010 Feb 4.
10
Acute Loss of Apolipoprotein E Triggers an Autoimmune Response That Accelerates Atherosclerosis.载脂蛋白 E 急性缺失引发自身免疫反应,加速动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):e145-e158. doi: 10.1161/ATVBAHA.118.310802.

引用本文的文献

1
Systems Approach to Integrating Preclinical Apolipoprotein E-Knockout Investigations Reveals Novel Etiologic Pathways and Master Atherosclerosis Network in Humans.系统方法整合临床前载脂蛋白 E 基因敲除研究揭示人类动脉粥样硬化新的病因学途径和主要网络。
Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):35-48. doi: 10.1161/ATVBAHA.121.317071. Epub 2021 Nov 11.
2
Regulatory T cells suppress the expression of COX-2 in vulnerable plaque.调节性T细胞抑制易损斑块中COX-2的表达。
Heart Vessels. 2020 Feb;35(2):278-283. doi: 10.1007/s00380-019-01491-1. Epub 2019 Sep 9.
3
Regulatory T cells protected against abdominal aortic aneurysm by suppression of the COX-2 expression.

本文引用的文献

1
HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis.高密度脂蛋白、ABC转运蛋白与胆固醇外流:对动脉粥样硬化治疗的意义
Cell Metab. 2008 May;7(5):365-75. doi: 10.1016/j.cmet.2008.03.001.
2
Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives.动脉粥样硬化中的环氧化酶和前列腺素合酶:最新见解与未来展望。
Pharmacol Ther. 2008 May;118(2):161-80. doi: 10.1016/j.pharmthera.2008.01.002. Epub 2008 Feb 2.
3
COX-2 inhibitors and cardiovascular risk.环氧化酶-2抑制剂与心血管风险。
调节性 T 细胞通过抑制 COX-2 表达来保护免受腹主动脉瘤的侵害。
J Cell Mol Med. 2019 Oct;23(10):6766-6774. doi: 10.1111/jcmm.14554. Epub 2019 Jul 21.
4
Myeloid HO-1 modulates macrophage polarization and protects against ischemia-reperfusion injury.髓系 HO-1 调节巨噬细胞极化并防止缺血再灌注损伤。
JCI Insight. 2018 Oct 4;3(19):120596. doi: 10.1172/jci.insight.120596.
5
Contribution of alveolar type II cell-derived cyclooxygenase-2 to basal airway function, lung inflammation, and lung fibrosis.肺泡II型细胞来源的环氧化酶-2对基础气道功能、肺部炎症和肺纤维化的作用。
FASEB J. 2016 Jan;30(1):160-73. doi: 10.1096/fj.14-268458. Epub 2015 Sep 22.
6
Interleukin 1 type 1 receptor restore: a genetic mouse model for studying interleukin 1 receptor-mediated effects in specific cell types.白细胞介素1Ⅰ型受体恢复:一种用于研究白细胞介素1受体在特定细胞类型中介导作用的基因小鼠模型。
J Neurosci. 2015 Feb 18;35(7):2860-70. doi: 10.1523/JNEUROSCI.3199-14.2015.
7
Prostacyclin mediates endothelial COX-2-dependent neuroprotective effects during excitotoxic brain injury.前列环素介导兴奋性脑损伤过程中内皮细胞 COX-2 依赖的神经保护作用。
J Inflamm Res. 2014 May 21;7:57-67. doi: 10.2147/JIR.S63205. eCollection 2014.
8
Hepatic ischemia and reperfusion injury in the absence of myeloid cell-derived COX-2 in mice.小鼠中缺乏髓样细胞衍生的COX-2时的肝脏缺血再灌注损伤
PLoS One. 2014 May 12;9(5):e96913. doi: 10.1371/journal.pone.0096913. eCollection 2014.
9
Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.新型 NOD.B10 近交系小鼠将干燥综合征口干候选染色体 1 疾病易感性基因缩小。
Clin Immunol. 2014 Jul;153(1):79-90. doi: 10.1016/j.clim.2014.03.012. Epub 2014 Mar 29.
10
Cell-type-specific roles for COX-2 in UVB-induced skin cancer.COX - 2在紫外线诱导的皮肤癌中的细胞类型特异性作用。
Carcinogenesis. 2014 Jun;35(6):1310-9. doi: 10.1093/carcin/bgu020. Epub 2014 Jan 27.
J Cardiovasc Pharmacol. 2007 Nov;50(5):470-9. doi: 10.1097/FJC.0b013e318157f72d.
4
The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.选择性环氧化酶-2抑制剂塞来昔布降低了载脂蛋白E基因敲除小鼠的动脉粥样硬化程度。
J Surg Res. 2008 May 1;146(1):135-42. doi: 10.1016/j.jss.2007.04.040. Epub 2007 Oct 22.
5
A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.COX-2的一种新型抗动脉粥样硬化作用——COX-2抑制剂心血管副作用的潜在机制。
Prostaglandins Other Lipid Mediat. 2007 Aug;84(1-2):24-33. doi: 10.1016/j.prostaglandins.2007.03.004. Epub 2007 Mar 14.
6
COX-2 expression in atherosclerosis: the good, the bad or the ugly?环氧化酶-2在动脉粥样硬化中的表达:有益、有害还是有害无益?
Curr Med Chem. 2007;14(15):1595-605. doi: 10.2174/092986707780830998.
7
Recent insights into the role of prostanoids in atherosclerotic vascular disease.近年来对前列腺素在动脉粥样硬化性血管疾病中作用的新见解。
Curr Vasc Pharmacol. 2006 Oct;4(4):395-408. doi: 10.2174/157016106778521652.
8
Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses.类二十烷酸跨细胞生物合成:从细胞间相互作用到体内组织反应
Pharmacol Rev. 2006 Sep;58(3):375-88. doi: 10.1124/pr.58.3.8.
9
Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.心血管风险与环氧化酶抑制:对环氧化酶-2选择性和非选择性抑制剂观察性研究的系统评价
JAMA. 2006 Oct 4;296(13):1633-44. doi: 10.1001/jama.296.13.jrv60011. Epub 2006 Sep 12.
10
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas.塞来昔布在两项预防结直肠腺瘤试验中对心血管事件和血压的影响。
Circulation. 2006 Sep 5;114(10):1028-35. doi: 10.1161/CIRCULATIONAHA.106.636746.